A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer: Residual disease in breast and nodes combined with Ki-67 (RDBN-K)
第一作者机构：[1]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Han Ruoqi,Liu Yueping,Ma Yanqi,et al.A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer: Residual disease in breast and nodes combined with Ki-67 (RDBN-K)[J].CANCER RESEARCH.2021,81(4):doi:10.1158/1538-7445.SABCS20-PS6-29.
APA：
Han, Ruoqi,Liu, Yueping,Ma, Yanqi,Liu, Zhikun,Li, Chunxiao&Geng, Cuizhi.(2021).A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer: Residual disease in breast and nodes combined with Ki-67 (RDBN-K).CANCER RESEARCH,81,(4)
MLA：
Han, Ruoqi,et al."A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer: Residual disease in breast and nodes combined with Ki-67 (RDBN-K)".CANCER RESEARCH 81..4(2021)
医学